This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Issue 7 (21st March 2022)
Record Type:
Journal Article
Title:
Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Issue 7 (21st March 2022)
Main Title:
Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial
Abstract : Expression of concern for 'Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial' by Alireza Mafi et al., Food Funct., 2018, 9, 4763–4770, DOI: ; https://doi.org/10.1039/C8FO00888D .